Loading...
Cryosite Limited
CTE.AX•ASX
HealthcareMedical - Diagnostics & Research
A$0.74
A$0.00(0.00%)
Cryosite Limited (CTE.AX) Financial Performance & Statements
Review Cryosite Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
5.67%
↑ 5.67%
Operating Income Growth
34.78%
↑ 34.78%
Net Income Growth
30.59%
↑ 30.59%
Operating Cash Flow Growth
94.69%
↑ 94.69%
Operating Margin
17.33%
↑ 17.33%
Gross Margin
61.43%
↑ 61.43%
Net Profit Margin
14.26%
↑ 14.26%
ROE
132.75%
↑ 132.75%
ROIC
15.10%
↑ 15.10%
Cryosite Limited (CTE.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Cryosite Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $6.21M | $6.40M | $6.21M | $5.72M |
| Cost of Revenue | $2.57M | $2.84M | $2.84M | $2.61M |
| Gross Profit | $3.64M | $3.56M | $3.37M | $3.11M |
| Gross Profit Ratio | $0.59 | $0.56 | $0.54 | $0.54 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.52M | $2.63M | $2.56M | $2.39M |
| Operating Expenses | $2.52M | $2.63M | $2.56M | $2.39M |
| Total Costs & Expenses | $5.09M | $5.47M | $5.40M | $5.009M |
| Interest Income | $85000.00 | $110000.00 | $70232.00 | $45768.00 |
| Interest Expense | $80000.00 | $83000.00 | $30311.00 | $0.00 |
| Depreciation & Amortization | $396000.00 | $391000.00 | $350813.00 | $345187.00 |
| EBITDA | $1.60M | $1.44M | $1.22M | $1.05M |
| EBITDA Ratio | $0.26 | $0.21 | $0.19 | $0.19 |
| Operating Income | $1.12M | $934000.00 | $810370.00 | $713640.00 |
| Operating Income Ratio | $0.18 | $0.15 | $0.13 | $0.12 |
| Other Income/Expenses (Net) | $5000.00 | $27000.00 | $61479.00 | -$10484.00 |
| Income Before Tax | $1.13M | $961000.00 | $871849.00 | $703151.00 |
| Income Before Tax Ratio | $0.18 | $0.15 | $0.14 | $0.12 |
| Income Tax Expense | $131000.00 | $115000.00 | $141591.00 | $24409.00 |
| Net Income | $994000.00 | $846000.00 | $730258.00 | $678742.00 |
| Net Income Ratio | $0.16 | $0.13 | $0.12 | $0.12 |
| EPS | $0.02 | $0.02 | $0.01 | $0.01 |
| Diluted EPS | $0.02 | $0.02 | $0.01 | $0.01 |
| Weighted Avg Shares Outstanding | $48.81M | $48.81M | $48.81M | $48.81M |
| Weighted Avg Shares Outstanding (Diluted) | $48.81M | $48.81M | $48.81M | $48.81M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan